MAPT and Alzheimer disease: The cerebrospinal fluid (CSF) biomarker profiles associated with AD consist of reduced concentration of beta-amyloid (Aβ42) and increased concentrations of total tau (T-Tau) and phosphorylated tau (P-Tau).